Snakebite antivenom study
Part of Injuries & trauma clinical trials.
This study is testing a new polyvalent antivenom called Premium-PANAF for treating snakebites in Ethiopia. It aims to see how well the antivenom works for people who have been bitten by venomous snakes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been bitten by a venomous snake and are receiving the study antivenom Premium-PANAF.
- You have not received any other antivenom treatment for this snakebite.
- You are able to understand and sign a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks households about snakebites to understand where and how often they happen. Your participation helps researchers learn how to reduce snakebite risks.
This trial compares two methods of immobilizing a snake bite: a pressure pad versus a pressure bandage. It uses a harmless radioactive tracer in healthy volunteers to see which method works better.
This study looks at how Bothrops snake venom affects a blood protein called von Willebrand factor, which helps with clotting. If you have been bitten by a Bothrops snake and have moderate to severe symptoms, you may be able to join to help doctors understand how to treat snakebites better.
This trial tests a snake antivenom called PANAF-Premium to see if it is safe and works well for people bitten by snakes. It is for anyone with signs of venom poisoning, and you can join even if you have had other snakebite treatments or are pregnant.
This trial tests an oral medication for people who have been bitten by a snake in the past 12 hours. The goal is to see if it can help reduce the effects of the venom.
This study looks at people who have been bitten by a snake to learn more about how snakebites affect the body and what treatments work best. It may help doctors improve care for future snakebite patients.
Hear when a new Snake Envenomation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.